These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 7888671)

  • 1. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance).
    Rosendaal FR; Koster T; Vandenbroucke JP; Reitsma PH
    Blood; 1995 Mar; 85(6):1504-8. PubMed ID: 7888671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives enhance the risk of clinical manifestation of venous thrombosis at a young age in females homozygous for factor V Leiden.
    Rintelen C; Mannhalter C; Ireland H; Lane DA; Knöbl P; Lechner K; Pabinger I
    Br J Haematol; 1996 May; 93(2):487-90. PubMed ID: 8639453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene.
    Rintelen C; Mannhalter C; Lechner K; Eichinger S; Kyrle PA; Papagiannopoulos M; Schneider B; Pabinger I
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):101-5. PubMed ID: 10192659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
    Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of oral contraceptives on hemostasis and thrombosis.
    Rosing J; Tans G
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S375-82. PubMed ID: 10368524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination between normal wildtype and carriers of coagulation factor V Leiden mutation by the activated protein C resistance test in the presence of factor V deficient plasma.
    Reuner KH; Litfin F; Patscheke H
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):41-5. PubMed ID: 9156566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of the Factor V Leiden Mutation Arg534Gln in Western Region of Saudi Arabia: Functional Alteration and Association Study With Different Populations.
    Athar M; Abduljaleel Z; Ghita IS; Albagenny AA; Halawani SH; Alkazmi MM; Elbjeirami WM; Alquthami K; Alkhuzae MM; Ragab FM; Al-Allaf FA
    Clin Appl Thromb Hemost; 2021; 27():1076029620978532. PubMed ID: 33448877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
    Rosing J; Tans G; Nicolaes GA; Thomassen MC; van Oerle R; van der Ploeg PM; Heijnen P; Hamulyak K; Hemker HC
    Br J Haematol; 1997 Apr; 97(1):233-8. PubMed ID: 9136971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A.
    Federici EH; Al-Mondhiry H
    Thromb Res; 2019 Oct; 182():75-78. PubMed ID: 31472339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Büller HR; Vandenbroucke JP
    Lancet; 1995 Dec; 346(8990):1593-6. PubMed ID: 7500751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of thrombosis in patients homozygous and heterozygous for factor V Leiden in the East Bohemian region.
    Dulícek P; Malý J; Safárová M
    Clin Appl Thromb Hemost; 2000 Apr; 6(2):87-9. PubMed ID: 10775028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coexistence of hereditary homocystinuria and factor V Leiden--effect on thrombosis.
    Mandel H; Brenner B; Berant M; Rosenberg N; Lanir N; Jakobs C; Fowler B; Seligsohn U
    N Engl J Med; 1996 Mar; 334(12):763-8. PubMed ID: 8592550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prothrombin fragment 1+2 and thrombin-antithrombin complex levels in patients with inherited APC resistance due to factor V Leiden mutation.
    Simioni P; Scarano L; Gavasso S; Sardella C; Girolami B; Scudeller A; Girolami A
    Br J Haematol; 1996 Feb; 92(2):435-41. PubMed ID: 8603014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
    Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA
    Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activated protein C resistance (factor V Leiden) associated with thrombosis in pregnancy.
    Hallak M; Senderowicz J; Cassel A; Shapira C; Aghai E; Auslender R; Abramovici H
    Am J Obstet Gynecol; 1997 Apr; 176(4):889-93. PubMed ID: 9125617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.